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Neural crestWe describe a mechanistic model whereby Foxd3, a forkhead transcription factor, prevents neural crest-
derived precursors from acquiring a melanophore fate. Foxd3 regulates this fate choice by repressing the
mitfa promoter in a subset of neural crest cells. mitfa is only expressed in a Foxd3-negative subset of neural
crest cells, and foxd3 mutants show an increase in the spatial domain of mitfa expression, thereby suggesting
that Foxd3 limits the mitfa domain. Furthermore, foxd3:gfp transgenic zebraﬁsh reveal foxd3 expression in
xanthophore precursors and iridophores, but not in terminally differentiated melanophores. Luciferase
experiments and embryo mRNA injections indicate Foxd3 acts directly on the mitfa promoter to negatively
regulate mitfa expression. Taken together, our data suggests the presence of Foxd3 in a subset of precursors
leads to mitfa repression and suppression of melanophore fate. MITF, the human mitfa ortholog, has recently
been described as an oncogene and implicated in various forms of melanoma. Understanding the
mechanisms that regulate mitfa and melanophore development could prove informative in the treatment
and prevention of these human diseases.© 2009 Elsevier Inc. All rights reserved.Introduction
The elucidation of the genetic mechanisms that transition a mul-
tipotent precursor towards a committed fate remains an important
focus of developmental biology. The neural crest-derived pigment
cells of the zebraﬁsh, Danio rerio, are a remarkably tractable system
for studying cell fate in vertebrate taxa. Pigment cells of the skin are
derived from the neural crest, a transient embryonic population of
cells that migrate through the animal to generate a diverse set of cell
types (reviewed by Cooper and Raible, 2009). Zebraﬁsh produce
three varieties of neural crest-derived pigment cells: the black
melanophore, the silver iridophore and the yellow xanthophore.
These pigment cells migrate across the zebraﬁsh and create colo-
ration patterns that affect the behavior and ecology of the organism.
Melanophores (or melanocytes) are broadly represented among
species from each vertebrate class, while xanthophores and irido-
phores are absent in the homoeothermic vertebrates, birds and
mammals (Braasch et al., 2006; Fujii, 2000). One hundred years of
mouse genetic research have elucidated many aspects of melano-e contacted at University of
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l rights reserved.phore biology, including the molecular pathways regulating melano-
blast development, the biochemistry of melanin production and the
dynamics of melanosome dispersal (Hoekstra, 2006; Kelsh, 2004; Lin
and Fisher, 2007; Parichy, 2006). However, less is known about the
mechanisms that act to dictate melanophore fate speciﬁcation. In this
study we describe an early event in pigment cell development in
zebraﬁsh, Danio rerio, which prevents a pigment precursor from
attaining a melanophore fate.
Positive regulators of melanophore development are well
deﬁned. In many animals the basic helix–loop–helix/leucine zipper
transcription factor Mitf acts as a master regulatory gene for black
pigment cell differentiation (Levy et al., 2006). Mitf is amongst the
earliest genes expressed in melanoblast precursors, and is necessary
and sufﬁcient for their development. Zebraﬁsh mutant for the Mitf
ortholog mitfa exhibit a complete absence of body melanophores
(Lister et al., 2001). Previous work has placed Mitf upstream of
multiple genes necessary for melanin production and terminally
differentiated melanophores including dopachrome tautomerase,
tyrosinase, tyrosinase-related protein-1, c-kit and bcl2 (reviewed by
Steingrimsson et al., 2004). Ectopic expression of Mitf is sufﬁcient to
confer melanophore characteristics (Lister et al., 1999; Planque et al.,
2004; Tachibana et al., 1996), demonstrating that it is necessary and
sufﬁcient for pigment cell speciﬁcation.
Several positive regulators of zebraﬁsh mitfa have been identiﬁed.
The transcription factor Sox10 directly drives melanophore cell fate
via the mitfa promoter (Elworthy et al., 2003), a regulatory relation-
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2000; Potterf et al., 2000; Verastegui et al., 2000). Transcription of
mitfa is also positively regulated by Wnt signals (Dorsky et al., 2000;
Larue and Delmas, 2006; Saito et al., 2003). However, both Sox10 and
Wnt signals play positive roles in multiple neural crest lineages
(reviewed by Raible, 2006) suggesting negative regulators of Mitf are
important for cell fate speciﬁcation.
Foxd3, awinged-helix transcription factor, is a good candidate for a
negative regulator of melanophore development. Originally identiﬁed
as a gene expressed in murine embryonic stem cells (Clevidence et al.,
1993; Hanna et al., 2002; Sutton et al., 1996), Foxd3 was later found to
exhibit highly conserved pre-migratory neural crest expression
throughout vertebrates (Hromas et al., 1999; Labosky and Kaestner,
1998; Odenthal and Nusslein-Volhard, 1998; Pohl and Knochel, 2001;
Sasai et al., 2001). More recently, Foxd3 has been shown to play a
functional role in the speciﬁcation of various downstream neural crest
derivatives (Ignatius et al., 2008; Lister et al., 2006; Montero-Balaguer
et al., 2006; Stewart et al., 2006; Teng et al., 2008). While Foxd3 has
been described as a transcriptional activator in muscle (Lee et al.,
2006), it likely acts as a transcriptional repressor in the neural crest
(Pohl and Knochel, 2001; Sasai et al., 2001; Yaklichkin et al., 2007).
Foxd3 represses the formation of melanocytes in chick embryos (Kos
et al., 2001), suggesting it is a key regulator of melanogenesis.
Recently, Ignatius et al. (2008) have shown that zebraﬁsh foxd3
genetically interacts with histone deacetylase and that Foxd3 protein
can bind the mitfa promoter in vitro, but no binding sites were
identiﬁed or functional tests reported. Here we examine the
functional consequence of this interaction.
We propose a model in which Foxd3 acts upon neural crest cells,
via the mitfa promoter, to prevent melanophore fate. foxd3 mutants
reveal an increase in the spatial domain of mitfa suggesting Foxd3
restricts mitfa expression. In a wild-type background, mitfa is only
expressed in a subset of neural crest cells that are negative for
Foxd3 protein, again suggesting Foxd3 limits the mitfa domain.
Furthermore, our foxd3:gfp transgenic zebraﬁsh reveals foxd3
expression in xanthophore precursors and iridophores but not ter-
minally differentiated melanophores. Luciferase experiments quan-
tify Foxd3's ability to repress the mitfa promoter in a winged-helix
domain dependent manner. Lastly, embryo mRNA injections recapi-
tulate the luciferase results in the context of a live zebraﬁsh. Taken
together, these results support a mechanism of cell speciﬁcation
whereby the absence of Foxd3 protein in pigment precursor cells
allows mitfa activation and, subsequently, melanophore cell fate.
Reciprocally, the presence of Foxd3 protein in other neural crest
cells maintains mitfa repression and, thereby, suppresses melano-
phore fate.
Materials and methods
Animal husbandry and establishment of transgenic lines
The Tg(mitfa:gfp)w47 transgenic line was generated by injecting
one-cell embryos with an agarose gel-puriﬁed Sal I/Not I restric-
tion fragment of the plasmid pNP-BEGFP, in which the CMV
promoter from the vector pCS2+BE-GFPLT was replaced with a
931-bp fragment of the mitfa promoter and 5′ UTR via the SalI and
HindIII sites. A single germline transgenic founder was identiﬁed
from 28 adult ﬁsh. Adult ﬁsh of the ⁎AB strain foxd3zdf1 (sym1;
Stewart et al., 2006), the transgenic line Tg(mitfa:gfp)w47 and the
transgenic line Tg(foxd3:gfp)zf15 (Gilmour et al., 2002) reporter
strains were maintained on a 14 h/10 h light/dark cycle at 28.5 °C.
Embryos for all experiments were obtained through natural crosses
and staged according to Kimmel et al. (1995). In some experi-
ments, phenylthiocarbamide (PTU; Sigma) was added to embryo
medium at a ﬁnal concentration of 0.2 mM to inhibit melanin
synthesis.Cell culture, transfections, immunostaining
B16 and NIH-3T3 cells were cultured in Dulbecco's Modiﬁed
Eagle's Medium (DMEM) containing 5% fetal bovine serum (Gibco)
supplementedwith 1× penicillin/streptomycin and incubated at 37 °C
in an atmosphere of 5% CO2. Fresh culturemediumwas provided every
2 days and the cells were sub-cultured before reaching 70%
conﬂuency. The melb-a mouse melanoblast cells (Sviderskaya et al.,
1995) were cultured in RPMI 1640 medium (Gibco) containing 10%
fetal bovine serum, stem cell factor (10 ng/ml) and FGF2 (40 pM)
supplementedwith 1× penicillin/streptomycin and incubated at 37 °C
in an atmosphere of 10% CO2. The pCS2-myc-tag Foxd3 plasmid used
for the melb-a cell overexpression assay was described previously
(ZDB-GENE-980526-143; Lister et al., 2006). The DNA-bindingmutant
form of pCS2-myc-tag Foxd3 (Foxd3 BM) was created using the
Quikchange mutagenesis protocol (Stratagene) with the following
oligonucleotides: forward, 5′-cca ttc gcc ata act ttt cgc tca acg act gct-
3′; reverse, 5′-agc agt cgt tga gcg aaa agt tat ggc gaa tgg-3′. The
mutation generated a single amino acid substitution in the winged-
helix domain: leucine to phenylalanine (L147F). The pCS2-snail1b
plasmid was made by cloning a full-length open reading frame (ZDB-
GENE-980526-514; Thisse et al., 1995) into pCS2 via HindIII and
BamHI sites. For the NIH-3T3 luciferase assay, the coding sequence of
zebraﬁsh sox10 (ZDB-GENE-011207-1; Dutton et al., 2001) was
ampliﬁed and subcloned into the vector pCS2-FLAG with three
amino terminal FLAG epitope tags. The mitfa proximal promoter
(GenBank accession # AF211890; Dorsky et al., 2000) was mutated
using the Quikchange mutagenesis protocol (Stratagene). Changed
base pairs are in lower case. Site 1 (nucleotides 579–588): 5′
ATGCTGAtggCAggggATGTTT 3′. Site 2 (nucleotides 750–761): 5′-
CGTTTGGGTAgggAAggagATATGA 3′. All constructs were conﬁrmed
by sequencing. About 1×105 cells were seeded into each well of a 24-
well plate (Falcon 3047) 24 h prior to transfection. Cells were
transfected by the lipofectaminemethod (Invitrogen) according to the
manufacturer's instructions. Transfection mixtures contained 1 μl of
lipofectamine and 0.8–1 μg of plasmid constructs per well in 24-well
plates. Reagents for the Galacto-Light chemiluminescent reporter
assay were from Tropix (Bedford, MA, USA) and D-Luciferin was from
Analytical Luminescence Laboratories (San Diego, CA, USA). Luciferase
output was standardized with beta-galactosidase activity. All trans-
fections and luciferase assays were performed independently and in
quadruplicate.
In situ hybridizations and immunohistochemistry
Digoxigenin-labeled riboprobe for mitfa (ZDB-GENE-990910-11;
Lister et al., 2006) and dct (ZDB-GENE-000508-1; Kelsh, 2000) has
been characterized previously. In situ hybridization was performed as
described previously (Lister et al., 1999), using NBT/BCIP as a
chromagenic substrate. Fluorescent in situ hybridization was per-
formed as described previously (Julich et al., 2005) using anti-Dig POD
for both dct and mitfa, Alexa-Fluor tyramide substrate 568 (Invitro-
gen) and Roche blocking reagent and buffer. The following antibodies
were used for immunohistochemistry at the indicated dilutions:
rabbit polyclonal anti-Foxd3 (Lister et al., 2006), 1:500; mouse
monoclonal anti-myc (Abcam), 1:1000; mouse monoclonal anti-Flag
(Sigma), 1:1000; mouse monoclonal anti-Pax3/7 (DP312) (Minchin
and Hughes, 2008), 1:500; rabbit polyclonal anti-MITF (Novus
Biological), rabbit polyclonal anti-Sox10 (Park et al., 2005), 1:1000;
1:500; anti-mouse (Alexa 488) and anti-rabbit (Alexa 568) secondary
antibodies (Invitrogen), 1:750; mouse monoclonal anti-Green Fluo-
rescent Protein (Invitrogen) and rabbit polyclonal anti-Green Fluo-
rescent Protein (Invitrogen), 1:500 in conjunction with anti-mouse
(Alexa 488), 1:1000 and anti-rabbit (Alexa 568), 1:1000 to boost
signal. Brightﬁeld images were obtained on a Nikon dissecting
microscope with a Spot RT Slider digital camera (Diagnostic Instru-
410 K. Curran et al. / Developmental Biology 332 (2009) 408–417ments). Fluorescent confocal images were obtained on a LSM 5 Pascal
confocal microscope (Zeiss). Whole images were processed for color
balancing and brightness/contrast using Photoshop CS4 (Adobe) and
formatted with Illustrator CS4 (Adobe).
Embryo injections
Full-length and capped foxd3 (100 pg/embryo), foxd3 DNA-
binding mutant (100 pg/embryo) and sox10 mRNA (18 pg/embryo)
were generated using mMessage mMachine (Ambion). Embryos for
injection were obtained from natural matings, injected at the one-cell
stage and imaged at shield stage (6–8 h post fertilization; hpf) using a
ﬂuorescent Nikon dissecting microscope with Spot camera.
Results
mitfa:gfp transgenic line reports mitfa positive melanoblasts
To observe zebraﬁsh melanoblasts in vivo we generated a GFP
reporter transgenic line using 931 bp of themitfa promoter and 5′ UTR
upstream of the mitfa start site. At 20 hpf mitfa:gfp is expressed in
lateral stripes along the dorsal aspect of the hindbrain and trunk
region (Fig. 1A). This pattern is indicative of migratory neural crestFig. 1. mitfa:gfp transgenic reportsmitfa positive melanoblasts. (A) Live GFP expression from
lateral stripes, dorsal view, anterior left, 10×. hb=hindbrain. (B) Live GFP expression from
(mv), lateral view, anterior left, 10×. (C, E)mitfa:gfp transgenic recapitulatesmitfa expression
bar=20 μm. (E) 40× scale bar=10 μm. 98.4% of mitfa:gfp cells (n=311) are mitfa positive
Green: GFP expression, Red: dct. (D) 20×. Scale bar=20 μm. (F) 40×. Scale bar=10 μm. Arro
positive cells (n=193) are dct positive.cells arising from the closing neural tube. By 26 hpf mitfa:gfp positive
cells are present dorsally at the posterior end of the zebraﬁsh and
ventrally throughout the head and anterior trunk region (Fig. 1B). To
conﬁrm the ﬁdelity of our mitfa:gfp transgenic, we co-labeled
transgenic embryos with anti-GFP and a mitfa riboprobe and counted
cells along the dorsal–lateral stripes. At 24 hpf, 98.4% ofmitfa:gfp cells
(n=311) are also positive for mitfa transcript (Figs. 1C, E). To conﬁrm
that cells positive for mitfa:gfp are melanoblasts and fated to become
melanophores, we examined transgenic embryos for co-expression of
GFP and dopochrome tautomerase (dct) mRNA (Figs. 1D, F). dct, also
known as tyrosinase-related protein-2, is a melanogenic enzyme
downstream of mitfa that resides in the melanosome membrane
within melanoblasts (Kelsh et al., 2000; Lister et al., 1999). Therefore,
at 24 hpf, one would expect a proportion ofmitfa positive cells to have
up-regulated dct expression. We found 55% of mitfa:gfp positive cells
(n=193) are dct positive. In conclusion, our mitfa:gfp transgenic
accurately marks mitfa positive melanoblasts at these stages.
mitfa expression is expanded in foxd3 mutants
If Foxd3 acts as a transcriptional repressor, one would expect to
observe higher overall mitfa expression or ectopic mitfa expressing
cells in foxd3mutant zebraﬁsh. To explore this regulatory relationship,20 hpf mitfa:gfp transgenic zebraﬁsh, streams of migratory neural crest cells arise from
26 hpf mitfa:gfp transgenic zebraﬁsh, mitfa positive neural crest cells migrate ventrally
, dorsal view, anterior left, 24 hpf. Green: GFP expression, red:mitfamRNA. (C) 20× scale
. (D, F) mitfa:gfp transgenic labels early melanoblasts, dorsal view, anterior left, 24 hpf.
w points tomitfa:gfp positive cell that has yet to activate dct expression. 55% ofmitfa:gfp
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expression in foxd3 mutant embryos using in situ hybridization. The
foxd3zdf1mutation is a nucleotide deletion that disrupts the forkhead
DNA-binding domain of the foxd3 gene (Stewart et al., 2006). At 40
hpf, we observe a spatial expansion of mitfa in the head region and
anterior trunk (Figs. 2A, D). At later time points, 48 and 60 hpf, the
increase in mitfa expression is noticeable, although less pronounced
(Figs. 2B, C, E, F). Similar results were recently reported by Ignatius et
al. (2008), who found mitfa signal in melanoblasts to be more robust
in foxd3 morpholino-injected zebraﬁsh than in uninjected controls.
Foxd3 and mitfa exhibit a mutually exclusive relationship in migratory
neural crest cells
Foxd3 expression is a robust marker of pre-migratory neural crest
but is down-regulated in a subset of cells as development proceeds,
possibly via an autoregulatory negative feedback mechanism (Lister
et al., 2006; Stewart et al., 2006). If Foxd3 acts to repress mitfa
expression, we would predict their distribution to be mutually exclu-
sive. To assess the relationship between mitfa and Foxd3 expression,
we used Tg(mitfa:gfp) zebraﬁsh and anti-Foxd3 antibody on a ﬁeld of
neural crest cells along the dorsal aspect of the anterior trunk region
of zebraﬁsh embryos (Figs. 3A, B). At 24 hpf, we ﬁnd that expression
of Foxd3 protein does not substantially overlap with mitfa:gfp.
Analysis of mitfa transcript by in situ hybridization conﬁrms this
relationship (Fig. 3C). To quantify the mutually exclusive relationship
between mitfa and Foxd3 expression, we looked at the earliest stages
of GFP transgene initiation to determine whether there was any
overlap in expression, and found that approximately 90% of GFP
positive cells were Foxd3 negative (Fig. 3D). In contrast, Sox10, a
known mitfa activator (Dutton et al., 2001) shows extensive overlap
(Fig. 3E). Cell counts reveal that 91.8% of mitfa:gfp positive cells
(n=250) are Sox10 positive at this stage.
Foxd3 expression is absent in melanophores, but present in iridophore
and xanthophore precursors
Using the previously characterized Tg(foxd3:gfp) zebraﬁsh
(Gilmour et al., 2002), we looked for foxd3 expression in the three
zebraﬁsh pigment cell types: xanthophores, iridophores and mela-
nophores. The thick yellow pigmentation in xanthophores obscures
cellular boundaries and makes accurate cell counts difﬁcult. To better
identify xanthophores at 27 hpf, we used the Pax3/7 antibody,Fig. 2.mitfa expression expanded in Foxd3 mutant.mitfamRNA expanded in head and anter
type zebraﬁsh (D–F) mitfa expression in foxd3−/− (sym1). (A, D) 40 hpf (B, E) 48 hpf (C,recently determined to be exclusively expressed in the xanthophore
lineage at this stage (Minchin and Hughes, 2008). We found 94% of
Pax3/7 xanthoblasts (n=165) are foxd3:gfp positive (Figs. 4A, B).
Terminally differentiated iridophores illuminate under incident
light, allowing accurate cell counts. At 72 hpf, we observed 88.3%
of differentiated iridophores (n=342) to be foxd3:gfp positive
(Figs. 4C, D). Terminally differentiated melanophores lie adjacent to
iridophores along the dorsal stripe at 72 hpf (Fig. 4D). These
melanophores display no overlapping foxd3:gfp expression, how-
ever, it is possible the melanin accumulation within melanophores
masks GFP expression. To address this concern, we treated ﬁsh
with the melanin synthesis blocker PTU at 24 hpf, then analyzed
foxd3:gfp expression in partially melanized zebraﬁsh at 72 hpf
(Figs. 4E, F). We observed foxd3:gfp expression in only 5% of mela-
nophores (n=314). We conclude that foxd3 expression is main-
tained in xanthophores and iridophores, however, foxd3 expression
is down-regulated in melanophores.
Foxd3 represses endogenous MITF in cell culture
To test whether Foxd3 expression is sufﬁcient to repress endo-
genous Mitf expression we transfected pCS2+ plasmid expressing
zebraﬁsh foxd3 under the CMV promoter into melb-a mouse
melanoblast cells. Melb-a cells constitutively express Mitf (Lei et al.,
2002). We then assayed expression of endogenous Mitf expression
with an anti-MITF antibody. Expression of Foxd3 strongly repressed
Mitf expression (Fig. 5A). In contrast, foxd3 with a leucine to
phenylalanine substitution in the DNA-binding, winged-helix domain
(L167F), a mutation of a highly conserved amino acid shown to block
DNA binding of Fox proteins in other systems (Hacker et al., 1995), was
incapable of repressing endogenous Mitf, implying Foxd3 must bind
directly to DNA to repress Mitf (Fig. 5B). To quantify the relationship
between Foxd3 and endogenous Mitf expression, cell counts were
performed (Fig. 5C). 96.5% of cells expressing Foxd3 repressed Mitf
expression (n=58). 2.2% of cells expressing Foxd3 binding mutant
repressed Mitf expression (n=47). We conclude that zebraﬁsh foxd3
prevents endogenous Mitf in cell culture.
Foxd3 represses the mitfa promoter in mouse ﬁbroblasts and mouse
melanoma cells
To determine whether Foxd3 could directly regulate the mitfa
promoter, we used a pGL3-SV40 luciferase reporter plasmid compri-ior trunk of Foxd3 mutant. Dorsal view, anterior left, 5×. (A–C)mitfa expression in wild-
F) 60 hpf.
Fig. 3. Foxd3 andmitfa expressed in separate populations of neural crest cells. (A)mitfa:gfp positive neural crest cells are mutually exclusive with Foxd3 positive cells, 18 hpf, lateral
view, anterior left, 10×. (B)mitfa:gfp up-regulates in Foxd3 negative neural crest cells, 18 hpf, dorsal view, anterior trunk region, 20×. (A, B) Red: Foxd3 Ab. Green: GFP expression in
mitfa:gfp transgenic line (C)mitfa up-regulates in Foxd3 negative neural crest cells, 24 hpf lateral view, anterior trunk region. Red: Foxd3 Ab. Green:mitfamRNA. 20×. (D) Cell counts of
mitfa:gfp positive cells derived from 40× confocal images of migratory neural crest cells at three time points: 15–16 hpf, 16–17 hpf and 17–18 hpf. Blue line=percent of totalmitfa:gfp
positive cells countedwhich are Foxd3 negative. Yellow line=percent of totalmitfa:gfp positive cells countedwhich are Foxd3 positive. Stage 15–16 hpf, 88% ofmitfa:gfp positive cells
are Foxd3 negative (583/664); 12% ofmitfa:gfp positive cells are Foxd3 positive (81/664). Stage 16–17 hpf, 89% ofmitfa:gfp positive cells are Foxd3 negative (497/560); 11% ofmitfa:
gfp positive cells are Foxd3 positive (63/495). Stage 17–18 hpf, 91% ofmitfa:gfp positive cells are Foxd3 negative (448/495); 9% ofmitfa:gfp positive cells are Foxd3 positive (47/495).
(E) mitfa:gfp positive neural crest cells overlap with Sox10 expression, 91.8% of 250 mitfa:gfp positive cells are Sox10 positive, 20 hpf, dorsal view, anterior left, 10× (inset 20×).
412 K. Curran et al. / Developmental Biology 332 (2009) 408–417sing 931 bp of the zebraﬁsh mitfa proximal promoter (Dorsky et al.,
2000) to perform luciferase assays in NIH-3T3 mouse ﬁbroblasts and
B16 mouse melanoma cell lines. In B16 melanoma cells, the mitfa
promoter has high basal activity. Co-transfection of the foxd3 plasmid
caused a 19-fold decrease in the activity of mitfa:luciferase as com-
pared to basalmitfa:luciferase alone (Fig. 6A). A similar co-transfection
using the DNA-binding mutant version of foxd3 resulted in a return tobasal mitfa:luciferase expression levels (Fig. 6A). Acting as a negative
control, snail1b, a transcriptional repressor with no known mitfa
activity, was transfected into the assay. snail1b failed to repress mitfa:
luciferase (Fig. 6A). Foxd3 transfection had no effect on luciferase
expression under control of an SV40 promoter (data not shown),
suggesting that mitfa control elements were necessary for repression.
Co-transfection with the transcriptional repressor snail1b (LaBonne
Fig. 4. foxd3 expression is absent in melanophores, but present in iridophores and xanthophore precursors. (A, B) foxd3:gfp maintains expression in xanthoblasts, 27 hpf, dorsal
view, anterior left. Green: anti-GFP, red: Pax3/7 (mouse DP312 Ab). 94% of Pax3/7 xanthoblasts (n=165) are foxd3:gfp positive. (A) 20×, scale bar=40 μm. (B) 40×, scale
bar=7.5 μm. (C, D) foxd3:gfpmaintains expression in iridophores, 72 hpf, lateral view, dorsal stripe, anterior left. Scale bar=25 μm. 88.3% of differentiated iridophores (n=342) are
foxd3:gfp positive. (C) Incident light reveals 4 iridophores. (D) Green: live foxd3:gfp. (E, F) foxd3:gfp expression absent in melanophores, 72 hpf, lateral view, yolk ball, anterior left,
embryo treated with PTU. Arrows: partially melanized melanophores, scale bar=90 μm. 5% of melanophores (n=314) express foxd3:gfp. (E) Brightﬁeld. (F) Green: live foxd3:gfp.
413K. Curran et al. / Developmental Biology 332 (2009) 408–417and Bronner-Fraser, 2000), failed to repress mitfa:luciferase, suggest-
ing that repression by Foxd3 was speciﬁc (Fig. 6A).
Transfections with an ectopic activator in NIH-3T3 cells conﬁrmed
the preceding results. NIH-3T3 cells have low basal activation ofmitfa:Fig. 5. Melb-a cell culture analysis displays Foxd3 repression of endogenous MITF expressi
polyclonal, green: anti-Myc mouse monoclonal. (A) Cells transfected with full-length zebra
transfected with DNA-binding mutant version of zebraﬁsh foxd3-myc display co-localize
transfection experiments. 56 melb-a cells transfected with full-length foxd3 became MITF ne
of zebraﬁsh foxd3 became MITF negative, 45 transfected cells remained positive.luciferase, as would be expected from a ﬁbroblast cell. To compensate
for low basal mitfa expression, sox10, a known mitfa activator
(Elworthy et al., 2003) was co-transfected to enact a 5 fold increase
over basal mitfa:luciferase expression levels (Fig. 6B). Co-transfectionon. (A, B) Transfected melb-a (mouse melanoblast) cells, (20×). Red: anti-MITF rabbit
ﬁsh foxd3-myc sequence show nuclear exclusion of endogenous mouse MITF. (B) Cells
d staining with endogenous mouse MITF. (C) Cell counts collected from 5 separate
gative, 2 remained positive. 1 melb-a cell transfected with DNA-binding mutant version
414 K. Curran et al. / Developmental Biology 332 (2009) 408–417of foxd3 with sox10 blocked the mitfa promoter activation normally
observed with sox10 alone (Fig. 6B). These data suggest Foxd3 can
antagonize Sox10's activation of the mitfa promoter. When foxd3
DNA-binding mutant was used, we observed no repression of sox10
activation (Fig. 6B). Taken together, these results suggest Foxd3
represses themitfa promoter by binding to DNA. Ignatius et al. (2008)
recently reported binding of Foxd3 to mitfa promoter DNA in vitro,
consistent with direct activation, and identiﬁed two putative Forkhead
binding sites but did not test them for function.We tested the function
of these presumptive Foxd3 binding sites in the mitfa promoter and
observed a partial relief of repression after the two sites were mutated(Fig. 6C). foxd3 transfections with NIH-3T3 cells yielded a 13 fold
repression using the full-length mitfa promoter (Fig. 6C). In contrast,
foxd3 transfections using our mutagenized S1,S2 mitfa promoter
yielded only a 2.5 fold repression (Fig. 6C). This suggests the S1 and S2
sites are involved with Foxd3 repression of mitfa, however, additional
Foxd3 binding sites may also be present or additional indirect mecha-
nisms may be at play.
Foxd3 represses the mitfa promoter in zebraﬁsh embryos
To examine mitfa promoter activity in live zebraﬁsh embryos, we
used a transient mRNA co-injection assay in the mitfa:gfp transgenic
zebraﬁsh. GFP is ﬁrst observed in melanophore precursors at 15–18
hpf, reﬂecting endogenous mitfa expression (Fig. 3D). Under normal
conditions, a 6 hpf shield stage embryo displays no GFP (Fig. 7B).
Injection of sox10 mRNA into one-celled stage mitfa:gfp embryos
results in robust precocious GFP expression at 6 hpf (Fig. 7D), recapi-
tulating sox10's effect onmitfa expression in zebraﬁsh (Elworthy et al.,
2003). Upon co-injection of both foxd3 mRNA and sox10 mRNA,
precociousmitfa:gfp expression is strikingly absent (Fig. 7F), while co-
injection of DNA-binding mutant foxd3 mRNA and sox10 mRNA
results in a return to the robust precocious GFP expression observed
with injections of sox10 alone (Fig. 7H). We conclude that, in an
overexpression assay in a live zebraﬁsh embryo, Foxd3 can prevent
mitfa:gfp expression in a manner dependent on its DNA-binding
domain.
Discussion
Our results demonstrate that Foxd3 can repress the activity of the
zebraﬁsh mitfa promoter and thus would inhibit melanophore
differentiation. These results are consistent with previous results in
avian embryos, where electroporation of Foxd3 inhibited melanocyte
differentiation (Kos et al., 2001). We also ﬁnd that transfection of
foxd3 into melb-a mouse melanoblast cells blocks Mitf expression.
However, we have not been able to test whether Foxd3 overexpression
in zebraﬁsh embryos alters melanophore differentiation because of its
earlier effects on axis speciﬁcation (Lister et al., 2006; Steiner et al.,
2006). We observed enhanced levels of mitfa signal in foxd3mutants,
consistent with the idea that Foxd3 represses mitfa. However, this
mitfa de-repression was spatially limited to the head and anterior
trunk region. Consistent with these observations, there is little change
in melanophore cell number in foxd3 mutants (Stewart et al., 2006).
These observations suggest that additional negative regulators of
mitfamight exist in other regions of the zebraﬁsh embryo, such as theFig. 6. Foxd3 represses the mitfa promoter in mouse ﬁbroblasts and mouse melanoma
cells. (A, B) Luciferase assays assess Foxd3 activity on 931-bp. region of zebraﬁsh mitfa
promoter (mitfa:luciferase construct). (A) B16mousemelanoma cells display high levels
of basal mitfa:luciferase activity. Basal mitfa:luciferase activity decreased 19-fold upon
co-transfection with full-length zebraﬁsh foxd3. Basal activity not signiﬁcantly altered
upon co-transfection with DNA-binding mutant version of zebraﬁsh foxd3. Negative
control: snail1b failed to repress basal mitfa:luciferase activity. (B) NIH-3T3 mouse
ﬁbroblast co-transfection with zebraﬁsh sox10 increases mitfa:luciferase activity 5 fold.
Transfections with mitfa:luciferase, sox10 and foxd3 results in 7.6 fold decrease from
mitfa:luciferase and sox10 activation alone. Transfections with mitfa:luciferase, sox10
and DNA-binding mutant version of foxd3 result in no signiﬁcant change from mitfa:
luciferase and sox10 activation. (C) NIH-3T3 mouse ﬁbroblast luciferase assays reveal
partial functionality of proposed Foxd3 binding sites on 931-bp. region of zebraﬁsh
mitfa promoter (mitfa:luciferase construct). Proposed Foxd3 binding sites (S1 and S2)
have been scrambled in the mitfa:luciferase (S1,S2 mutant) construct. (C) Transfections
with mitfa:luciferase, sox10 and foxd3 results in a 13 fold decrease from mitfa:luciferase
and sox10 activation alone. Transfections with mitfa:luciferase, sox10 and DNA-binding
mutant version of foxd3 result in no signiﬁcant change from mitfa:luciferase and sox10
activation. Transfections withmitfa:luciferase (S1,S2 mutant), sox10 and foxd3 results in
only a 2.5 fold decrease frommitfa:luciferase (S1,S2 mutant) and sox10 activation alone.
Transfections with mitfa:luciferase (S1,S2 mutant), sox10 and DNA-binding mutant
version of foxd3 result in no signiﬁcant change frommitfa:luciferase (S1,S2 mutant) and
sox10 activation alone. (A–C) Data are means+/−standard deviation.
Fig. 7. Foxd3 represses themitfa promoter in zebraﬁsh embryos. (A–H) One-cellmitfa:gfp transgenic zebraﬁsh embryos microinjected with mRNA and imaged live at 6–7 hpf, shield
stage 5×. (A, C, E, G) Brightﬁeld images. (B, D, F, H) Green: live GFP expression frommitfa:gfp. (A, B) Un-injected embryos reveal no ﬂuorescence at shield stage (observed in 64/64
embryos). (C, D) Embryos injected with sox10mRNA produce robust, precocious mitfa:gfp expression at shield stage (observed in 62/64 embryos). (E, F) Co-injection of full-length
foxd3with sox10mRNA preventsmitfa:gfp expression at shield stage (observed in 47/52 embryos). (G, H) Embryos co-injected with sox10 and DNA-binding mutant version of foxd3
mRNA display a return to robust, precocious mitfa:gfp expression at shield stage (observed in 43/49 embryos).
415K. Curran et al. / Developmental Biology 332 (2009) 408–417posterior trunk and tail. Additionally, speciﬁc activators are needed in
addition to loss of repression to increase mitfa expression.
Our data are consistent with Foxd3 acting directly as a transcrip-
tional repressor on the mitfa promoter. Foxd3 has been demonstrated
to act as a repressor in other systems (Pohl and Knochel, 2001;
Yaklichkin et al., 2007). Foxd3 might regulatemitfa indirectly throughprotein–protein interactions rather than directly by promoter binding.
However, several lines of evidence support a direct interaction. We
found that transfection of foxd3 inhibits the effects of exogenously
supplied sox10 activator in our assays with NIH-3T3 cells, suggesting a
direct action. Additionally, introducing the L167F mutation into the
winged-helix domain of Foxd3, a mutation of a highly conserved
416 K. Curran et al. / Developmental Biology 332 (2009) 408–417amino acid shown to block DNA binding of Fox proteins in other
systems (Hacker et al., 1995), eliminated the effects of Foxd3 onmitfa.
However, it is possible that Foxd3 interfered with an endogenous co-
activator that was not sufﬁcient to activate mitfa on its own. There
remains the possibility that a properly conﬁgured winged-helix
domain might be necessary for interaction with other proteins if
Foxd3 were interacting independently of direct DNA binding. There is
some precedent for this idea: Guo et al. (2002) utilized immunopre-
cipitation assays to show Oct-4 physically interacts with the DNA-
binding domain of FoxD3. In this manner, Oct-4 acts as a co-repressor
modulating Foxd3 repressive activity in mammalian endoderm deve-
lopment. It is possible similar protein co-repressors are responsible for
modulating Foxd3 activity in our assays. However, we observed Foxd3
repression of mitfa in mouse melanoblast (melb-a cells), mouse
melanoma (B16 cells), mouse ﬁbroblast (NIH-3T3 cells) and zebraﬁsh
embryos. Therefore, if protein–protein co-repressors are involved, this
indirect interaction must be present in each of these four systems.
We have not been able to demonstrate consistent interactions
of Foxd3 protein with the mitfa promoter in vitro, suggesting direct
interactions may be of low afﬁnity. We note that Ignatius et al.
(2008) utilized electromobility shift assays to determine that Foxd3
binds two sites from the mitfa promoter. When we mutated these
sites and tested them in luciferase assays, we found that inhibition
was alleviated from a 13 fold to a 2.5 fold repression. This partial
relief of repression suggests that additional Foxd3 binding sites
may be present on the mitfa promoter or that indirect, protein–
protein interactions are at play.
The repression of mitfa by foxd3 sheds light on the possible
mechanism behind the genetic interaction between foxd3 and kit, a
receptor tyrosine kinase necessary for melanophore survival (Cooper
et al., 2009). Inactivation of foxd3 partially rescues melanophore cell
death seen in kitmutants. Since Mitf is a positive activator of the pro-
survival gene bcl2 (McGill et al., 2002), inhibition of Mitf by Foxd3
would be expected to promote cell death. Inactivation of Foxd3 in turn
would release this inhibition and have pro-survival effects that might
partially overcome the loss of Kit function.
Our foxd3:gfp data suggests that, within pigment cells, Foxd3
repression is unique to melanophores. Xanthoblasts and iridophores
maintain foxd3:gfp expression, suggesting Foxd3 does not interfere
with their development and differentiation. Foxd3 appears to play a
positive role in iridophore speciﬁcation as iridophores are strongly
reduced in both foxd3zdf1 mutant zebraﬁsh (Stewart et al., 2006) and
in foxd3 morphant zebraﬁsh (Lister et al., 2006). Therefore, the
restricted spatial expansion of mitfa observed in the foxd3zdf1 mutant
may represent ectopic mitfa expression in a pigment precursor
population of neural crest cells. Interestingly,mitfa exerts a repressive
role on iridophore development, as seen in increased cell counts of
larval trunk and tail iridophores in mitfa mutants as compared to
wild-type zebraﬁsh (Lister et al., 1999). Fully understanding the
possible mechanisms by which Foxd3 regulates transcription will be
necessary to determine how Foxd3 acts to promote the development
of other neural crest lineages, such as iridophores, peripheral neurons
and glial cells.
While this work was under review, Thomas and Erickson (2009)
described a similar inhibitory regulation of the avian MITF gene by
FOXD3. In this study, FOXD3 regulated MITF indirectly through
protein–protein interactions with PAX3, a positive regulator of Mitf
in avian and mammalian species (Watanabe et al., 1998). In zebraﬁsh,
Pax3 does not regulate melanophores but rather xanthophores
(Minchin and Hughes, 2008), and we ﬁnd no evidence of regulation
of the zebraﬁsh mitfa promoter by Pax3 (J.A.L., unpublished). Thus
while the regulatory interactions between Foxd3 and Mitf may be
widely conserved, speciﬁc mechanisms may vary. Thomas and
Erickson (2009) provide evidence for the regulatory interaction
between Foxd3 and Mitf playing a role in regulating glial cell deve-
lopment, suggesting that this interaction may have more widespreadeffects on neural crest development than the regulation of pigment cell
precursors described here.
Our work regarding Foxd3 repression of mitfa corroborates with
previous ﬁndings from mammalian melanocyte research (reviewed
by Harris and Erickson, 2007). The conservation of genetic mecha-
nisms regulating melanogenesis across vertebrates makes the
tractable zebraﬁsh system an attractive tool to study human diseases
associated with melanocytes. A recent study has correlated the
occurrence of vitiligo, a chronic skin condition causing hypo-pigmen-
tation, in one family to a single base change (GNT) which up-
regulates Foxd3 promoter activity in cultured cells (Alkhateeb et al.,
2005). Furthermore, MITF has recently proven to be an ampliﬁed
oncogene in a signiﬁcant fraction of human melanomas and to play
an oncogenic role in human clear cell sarcoma (Levy et al., 2006).
Understanding the molecular mechanisms that properly repress
mitfa expression may offer insight into improved strategies for
treating these life-threatening diseases.
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